Search Results for "Growth"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Growth. Results 281 to 290 of 298 total matches.
Acute Reactions to Drugs of Abuse
The Medical Letter on Drugs and Therapeutics • Mar 04, 2002 (Issue 1125)
such
as ataxia, and complications of pregnancy including fetal growth retardation and perinatal
death. Dermal ...
Acute toxic reactions to drugs of abuse continue to be important problems. Some patients may have mixed intoxications with complex combinations of signs and symptoms.
In Brief: One Drop or Two
The Medical Letter on Drugs and Therapeutics • Jun 19, 2006 (Issue 1237)
to the labeling of all
ADHD drugs against use in such patients.
3
Mild
growth suppression has been reported ...
Many prescriptions for eye drops call for instillation of 1-2 drops. But Medical Letter consultants in ophthalmology seem to agree that all eye drops should generally be given in doses of only one drop. The volume of a single drop can vary with the viscosity of the solution, the design of the dropper, and patient technique. The average volume of a drop is 35-50 microliters, but can be as high as 75 microliters. An eye brimming with fluid holds 30 microliters at best, so even one drop is often an overdose. A second either washes out the first or increases the possibility of systemic toxicity,...
Two New Drugs for Glaucoma
The Medical Letter on Drugs and Therapeutics • Jul 16, 2018 (Issue 1551)
pigmentation.10
In the pivotal trials, there was one report of hyperpigmentation
and one of eyelash growth ...
The FDA has approved two new ophthalmic drugs for
reduction of intraocular pressure (IOP) in patients with
open-angle glaucoma or ocular hypertension: latanoprostene
bunod (Vyzulta – Bausch and Lomb), a modified
prostaglandin analog, and netarsudil (VRhopressa – Aerie),
the first Rho kinase inhibitor to be approved in the US.
Drugs for Common Eye Disorders
The Medical Letter on Drugs and Therapeutics • Dec 02, 2019 (Issue 1586)
mediator of
neovascularization in wet AMD is thought to be
vascular endothelial growth factor (VEGF ...
This issue includes reviews of drugs for glaucoma,
age-related macular degeneration (AMD), bacterial
conjunctivitis, and dry eye disease. Allergic conjunctivitis
is reviewed in a separate issue.
Treatment of Allergic Rhinitis and Allergic Conjunctivitis
The Medical Letter on Drugs and Therapeutics • Mar 31, 2025 (Issue 1725)
has been associated with
small decreases in growth velocity.12
MONTELUKAST — The oral leukotriene receptor ...
Initial treatment of allergic rhinitis (AR) depends
on the severity of symptoms and whether they are
intermittent or persistent (see Table 1).
Med Lett Drugs Ther. 2025 Mar 31;67(1725):49-56 doi:10.58347/tml.2025.1725a | Show Introduction Hide Introduction
Comparison Chart: Some Drugs for HFrEF
The Medical Letter on Drugs and Therapeutics • May 26, 2025 (Issue 1729)
PREGNANCY and LACTATION
PREGNANCY and LACTATION
.
Have been associated with fetal growth ...
View the Comparison Chart: Some Drugs for HFrEF
Med Lett Drugs Ther. 2025 May 26;67(1729):e1-15 doi:10.58347/tml.2025.1729b | Show Introduction Hide Introduction
Drugs for Age-Related Macular Degeneration
The Medical Letter on Drugs and Therapeutics • Jan 06, 2025 (Issue 1719)
is thought to be vascular
endothelial growth factor (VEGF), which induces
angiogenesis and increases ...
Age-related macular degeneration (AMD) has two
major forms: dry or non-neovascular (~90% of
patients) and wet or neovascular (~10% of patients).
Med Lett Drugs Ther. 2025 Jan 6;67(1719):1-5 doi:10.58347/tml.2025.1719a | Show Introduction Hide Introduction
Management of Opioid Withdrawal Symptoms
The Medical Letter on Drugs and Therapeutics • Aug 27, 2018 (Issue 1554)
with an
increased risk of complications such as preeclampsia,
miscarriage, reduced fetal growth, fetal death ...
Pharmacologic management of opioid withdrawal
symptoms can reduce the intensity of drug craving
and improve treatment retention in patients with opioid
use disorder who will receive maintenance treatment.
Withdrawal management without subsequent maintenance
treatment is associated with high rates of
relapse, overdose death, and HIV and/or hepatitis C
virus infection. Several guidelines on management
of opioid withdrawal are available. Maintenance
treatment of opioid use disorder was reviewed in a
previous issue.
Comparison Table: Some Drugs for Plaque Psoriasis (online only)
The Medical Letter on Drugs and Therapeutics • Sep 30, 2024 (Issue 1712)
corticosteroids
during pregnancy has
been associated with fetal
growth restriction
▶ Combination is more ...
View the Comparison Table: Some Drugs for Plaque Psoriasis
Med Lett Drugs Ther. 2024 Sep 30;66(1712):e160-6 doi:10.58347/tml.2024.1712b | Show Introduction Hide Introduction
Drugs for Common Bacterial Infections in Adults
The Medical Letter on Drugs and Therapeutics • Oct 23, 2017 (Issue 1532)
and tetracycline
hydrochloride: tooth discoloration and dys pla sia; inhibition
of bone growth in fetus; hepatic ...
Bacterial infections in adults are generally treated
empirically, with the antibiotic covering most, but not
all, of the potential causative pathogens. For some
infections, culture and sensitivity testing can guide
treatment, allowing for use of narrower-spectrum
antibiotics. The recommended dosages and durations
of antibiotic treatment for common respiratory, skin, and
urinary tract infections are listed in Tables 1-3. Infectious
disease experts now recommend shorter treatment
durations for many infections to reduce the development
of antimicrobial resistance and minimize adverse...